关于刺五加注射液对大鼠大脑中动脉栓塞所致脑缺血损伤的保护作用

论文价格:0元/篇 论文用途:仅供参考 编辑:论文网 点击次数:0
论文字数:**** 论文编号:lw202397377 日期:2025-03-19 来源:论文网

       作者:路志红 熊利泽 王强 郑玉 张西京


【关键词】 脑缺血
  关键词: 刺五加;注射剂;脑缺血;剂量-效应关系,药物
  摘 要:目的 探讨刺五加(AS)注射液对脑缺血性损伤的保护作用及量效关系. 方法 40只雄性SD大鼠,随机分为四组(各组n=10),即对照组和AS-2.5,AS-5,AS-7.5组,分别在缺血前腹腔注射生理盐水7.5mL和刺五加注射液2.5mL,5.0mL(均用生理盐水稀释至7.5mL),7.5mL.采用颈内动脉尼龙线线栓法致大脑中动脉栓塞(120min)模型,观察再灌注后24h时神经功能损害并取大脑行TTC染色以测量脑梗死容积. 结果 再灌注24h时神经功能损害评分,对照组为(2.2±0.8),明显高于各保护组:AS-2.5组(1.3±0.8)、AS-5.0组(1.2±0.8)、AS-7.5组(1.2±0.6),P&<0.05.脑梗死容积对照组为(220±66)mm3 ,明显大于各保护组[AS-2.5组为(116±86)mm3 ,AS-5.0组为(121±79)mm3, AS-7.5组为(104±54)mm3 ],P&<0.05.各保护组之间神经功能损害评分和脑梗死容积无明显差别. 结论 刺五加注射液对短暂性局灶性脑缺血损伤呈非剂量依赖性保护作用.

  
  Keywords:acanthopanax senticosus;injection;cerebral is-chemia;dose-response relationship,drug
  
  Abstract:AIM To investigate the protective effect of acan-thopanax senticosus(AS)injection,an intravenous drug made from traditional Chinese herb,on transient focal cere-bral ischemic injury in rats.METHODS Forty male SD rats were randomly pided into4groups:Control group(n=10)
received no pharmacologic intervention but normal saline7.5mL,Group AS-2.5(n=10),AS-5(n=10),AS-7.5(n=10)received intraperitoneally acanthopanax senticosus injec-tion2.5mL,5mL(diluted to7.5mL with normal saline)and7.5mL respectively just before middle cerebral artery oc-clusion(MCAO)with3-0nylon monofilament for120min.The neurological outcome was evaluated at24h after reperfu-sion.The infarct volume was then assessed by TTC staining.RESULTS The neurologic deficit score(NDS)of Group AS-2.5(1.3±0.8),Group AS-5(1.2±0.8)and Group AS-7.5(1.2±0.6)at24h after reperfusion was lower than that of the Control group(2.2±0.8),P&<0.05.The infarct volume of the Control group(220±66)mm3 was significantly larger than those of the other three groups [AS-2.5:(116±86)mm3 ,AS-5.0:(121±79)mm3 ,AS-7.5:(104±54)mm3 ]at24h after reperfusion.There was no difference a-mong AS-treated groups for NDS and infarct volume.CON┐CLUSION Acanthopanax senticosus injection significantly reduces neurologic injury induced by transient MCAO with-out dose-response effect.
  
  0 引言
  
  刺五加(acanthopanax senticosus,AS)注射液主要活性成分为刺五加皂甙(acanthopanax sentico-side,ASS),临床初步验证对缺血性脑血管病有一定的疗效[1] .实验研究也证实ASS对犬、猫和大鼠心肌缺血再灌注损伤均有保护作用[2-4] .但迄今无刺五加注射液对与人类中风较为类似的大脑中动脉阻塞(middle cerebral artery occlusion,MCAO)致大鼠脑缺血性损伤影响的研究.因此,我们观察了AS注射液对大鼠MCAO致局灶性脑缺血的保护作用.
  
  1 材料和方法
  
  1.1 材料 40只雄性SD大鼠300~350g(第四军医大学实验动物中心),随机分为4组:对照组(control n=10)、AS-2.5组(n=10)、AS-5.0组(n=10)和AS-7.5组(n=10),分别于阻闭大脑中动脉前ip生理盐水7.5mL,AS注射液2.5mL,5.0mL(均用生理盐水稀释至7.5mL),7.5mL.AS注射液(黑龙江乌苏里江制药有限公司,批号:300416号).
  1.2 方法
  
  1.2.1 局灶性脑缺血模型 术前禁食12h,不禁水.动物用40mL L-1 异氟醚诱导麻醉,20mL L-1 异氟醚吸入维持麻醉深度,保留自主呼吸.术中体温由肛温探头连接多功能监测仪(Spacelab,USA)监测,并用烤灯维持在37.0℃~37.5℃.大脑中动脉阻闭(middle cerebral artery occlusion,MCAO)模型采用右侧颈内动脉尼龙线线栓法,根据Tatlisumak等[5] 的方法,并参照我们以前的报道[6-8] ,即动物麻醉后取颈正中切口,暴露右侧颈总动脉、颈外动脉及颈内动脉,结扎颈总动脉、颈外动脉,于颈总动脉分叉下方剪一切口,将一预先用乙醇灯烧成圆头的尼龙线(3-0,ETHICON,Japan)置入颈内动脉17.5mm,直到有轻微阻力感为止.阻闭120min后抽出尼龙线,恢复再灌注.
  
  1.2.2 动物恢复及神经行为学评估 麻醉苏醒后,将动物放回鼠笼,自由饮食.脑缺血再灌注后24h,由一不了解分组情况的观察者评估记录神经行为学评分,按Longa等[9] 的6级评分法:0级,无功能障碍;1级,不能伸展左侧前肢;2级,向左侧旋转;3级,向左侧倾倒;4级,无自主活动伴意识抑制;5级,死亡.
  
  1.2.3 脑梗死灶测量 24h神经行为学评分完成后,动物用0.2g L-1 戊巴比妥钠深麻醉后处死,迅速取出鼠脑,置于冰盐水中10min,取冠状面均匀切成2mm厚脑片,迅速放入0.2g L-1 TTC溶液(37℃)中染色30min,然后用40g L-1 甲醛缓冲液固定.24h后用数码相机(KODAK,DC240USA)拍照,输入计算机,用图像处理软件(ADOBE,PHOTOSHOP5.0)计算梗死面积(粉红色区为正常脑组织,白色区为梗死区),各脑片梗死面积之和乘以厚度(2mm)为总的梗死容积.
  
  统计学处理:数值用x ±s表示.梗死容积用单因素方差分析方法(ANOVA)统计.神经行为学评分用Kruskal-Wallis方法检验.P&<0.05表示统计学差异明显.
  
  2 结果
  
  2.1 神经行为学改变 术后动物均存活.24h时神经功能损害评分对照组(2.2±0.8)明显高于AS-2.5组(1.3±0.8,P&<0.05)、AS-5.0组(1.2±0.8,P&<0.05)、AS-7.5组(1.2±0.6,P&<0.05),各处理组间神经功能损害评分无差异(Tab1).
  表1 缺血(120min)再灌注后24h时各组鼠神经功能损害评分 略
  
  2.2 脑梗死容积 再灌注24h时脑梗死容积,对照组为(220±66)mm3 ,AS-2.5组为(116±86)mm3 ,AS-5.0组为(121±79)mm3 ,AS-7.5组为(104±54)mm3 ,各处理组梗死容积均明显小于对照组(P&<0.05),而各处理组间无显著差异(Fig1).
  
  图1 略
  
  3 讨论
  
  我们首次应用大鼠MCAO模型,研究了AS注射液对局灶性脑缺血再灌注损伤的保护作用,结果表明腹腔注射AS注射液2.5,5.0,7.5mL可明显减少大脑梗死容积,显著改善大鼠的神经功能缺陷症状.
  
  关于中药治疗脑缺血方面的研究已有很多[10] .AS为AS科植物,《神农本草经》列为上品,近年来受到国内外学者的关注.AS注射液系AS的茎叶用常规方法制成的灭菌水溶液,其主要活性成分为ASS[11] .AS可以促进蛋白质、核酸及ATP合成,提高细胞抵御损伤的能力,在临床上被用于脑出血、脑缺血、心肌缺血、糖尿病等疾病的治疗[12,13] ,亦可以提高机体对疲劳及寒冷的耐受力.动物实验表明AS对犬实验性心肌梗死及猫脑梗死也有防治作用[2,3] ,Tian等[4] 证实AS可改善大鼠离体心脏缺血再灌后的心律失常.
  
  近年来,随着对缺血性脑损伤病理生理研究的不断深入,已从分子水平上揭示了自由基在缺血细胞损伤中的重要作用[14,15] .中药减少自由基的报道也有很多[16] .实验研究证实AS能明显抑制机体内自由基产生,显著增加机体SOD活性[1,17] ,从而对脑缺血再灌注损伤产生明显的保护作用.同时AS可改善血小板凝聚功能,降低血液粘度,增加脑血流量,改善脑组织血供,从而增加脑部供氧,减轻缺血再灌注损伤.药理学研究表明ASS的单体SC1 ,SC3 ,Sb 均具有钙通道阻滞作用[18,19] .

转贴于  本研究发现AS注射液对大鼠局灶性脑缺血损伤也有保护作用,与以往研究结果一致,且该保护作用无明显剂量-效应关系.为AS注射液的临床应用提供了实验依据.
  毒理学研究证实AS几乎无毒性.长期给药,无明显毒性反应.小鼠急性毒性试验,皮下注射ASS的LD50 为4.75g kg-1 .刺五加醇提取液按18g kg-1 (人用量×60倍)、30g kg-1 (人用量×100倍)给兔灌胃,1次 d
-1 ,连续15d,灌药前后血清谷丙转氨酶、麝香草酚浊度与碘反应无显著差异,心、肝、肾、脾等实质性脏器无明显变化.可见其应用剂量安全范围宽.且其在我国北方广泛栽培,药源充足,临床可以广泛推广.
  
  总之,本研究证明AS注射液对大鼠脑缺血再灌注损伤有明显保护作用,且无明显剂量效应关系.
 
  

参考文献


  
  [1]Han LY,Cai DF.Clinical and experimental study on treatment of acute cerebral infarction with acanthopanax injection [J].Zhongguo Zhongxiyi Jiehe Zazhi(Chin J Integ Trad West Med),1998;18(8):472-474.
  [2]Sui DY,Lu ZZ,Ma LN,Fan ZG.Effects of the leaves of acan-thopanax senticosus harms on myocardial infarct size in acute is-chemic dogs [J].Zhongguo Zhongyao Zazhi(Chin J Chin Mat Med),1994;19(12):746-747.
  [3]Hibasami H,Fujikawa T,Takeda H,Nishibe S,Satoh T,Fuji-sawa T,Nakashima K.Induction of apoptosis by Acanthopanax senticosus harms and its component,sesamin in human stomach cancer KATOⅢcells [J].Oncol Rep,2000;7(6):1213-1216.
  [4]Tian BJ,Gao TL,Song ZL.Effects of Ciwujia(acanthopanax senticosus harms)on reperfusion induced arrhythmias and action potential alterations in isolated rat heart [J ].Zhongguo Zhongyao Zazhi(Chin J Chin Mat Med),1989;14(8):45-47,60.
  [5]Tatlisumak T,Takano K,Carano RA,Miller LP,Foster AC,Fisher M.Delayed treatment with an adenosine kinase inhibitor,GP683,attenuates infarct size in rats with temporary middle
   cerebral artery occlusion [J].Stroke,1998;29:1952-1958.
  [6]Xiong LZ,Zhu ZH,Dong HL,Hou LC,Chen SY.Isoflurane preconditioning induces ischemic tolerance in MCAO rats [J].Di-si Junyi Daxue Xuebao(J Fourth Mil Med Univ),2001;22(5):474-476.
  [7]Zhu ZH,Xiong LZ,Dong HL,Hu WN,Chen SY.Protection of Shenfu injection against transient ischemia in middle cerebral artery occlusion rat model [J].Zhongguo Zhongxiyi Jiehe Jijiu Zazhi(Chin J Integ Trad West Med Emerg),2001;8(2):79-81.
  [8]Xiong LZ,Zhu ZH,Dong HL,Hu WN,Hou LC,Chen SY.Hyperbaric oxygen preconditioning induces neuroprotection a-gainst ischemia in transient not permanent middle cerebral artery occlusion rat model [J].Zhonghua Yixue Zazhi(Chin Med J),2000;113(9):836-839.
  [9]Longa EZ,Weinstein PR,Carlson S,Cummins R.Reversible middle cerebral artery occlusion without craniectomy in rats [J].Stroke,1989;20:84-91.
  [10]Zhu ZH,Xiong LZ,Dong HL,Hu WN,Hou LC.Study on the protective effect of Shenfu injection against ischemic spinal cord injury in rabbits [J].Di-si Junyi Daxue Xuebao(J Fourth Mil Med Univ),2000;21(3):278-282.
  [11]Park SY,Chang SY,Yook CS,Nohara T.New3,4-seco-lu-pane-type triterpene glycosides from Acanthopanax senticosus forma inermis [J].J Nat Prod,2000;63(12):1630-1633.
  [12]Liu CL,Wang SG,Yang LJ.Clinical researches of treatment of acanthopanax injection on coronary artery disease [J].Shizhen Guoyao Yanjiu(Shizhen Res Chin Trad Med),1995;6(1):8-9.
  [13]Zhang YH,Wang QH,Xue YM,Shi J.Effects of acanthopanax senticosi on superoxide dismutase and malonydialdehyde in treat-ing patients with non-insulin dependant diabetes mellitus [J].Yunnan Zhongyi Zhongyao Zazhi(Yunnan J Chin Trad Med),1997;18(3):25-26.
  [14]Schmid-ELsaesser R,Hungerhuber E,Zausinger S,Baethmann A,ReuLen HJ.Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transent focal ischemia [J].Brain Res,1999;816:471-479.
  [15]Li SH,Zhang X,Fei ZH,Liu XZ,Liang JW,Li ZY.Changes of free radical and superoxide dismutase levels in brain tissues after diffuse traumatic brain injury and with secondary insults in rats [J].Di-si Junyi Daxue Xuebao(J Fourth Mil Med Univ),2000;21(10):1295-1297.
  [16]Wang XL,Li YC,Hou YC.Jingguishenqi pill has anti-aging ef-fect [J].Di-si Junyi Daxue Xuebao(J Fourth Mil Med Univ),2000;21(10):1209-1211.
  [17]Ni JS,Wu JX,Xiao RQ,Shi B,Wang XR,Liu SX.Effect of eleutheroside on serum LPO and SOD in diabetic rats [J].Bai-qiu-en Yike Daxue Xuebao(J Norman Bethune Univ Med Sci),1998;24(1):33-34.
  [18]Zhan S,Zhang WJ,Zhong GG.Influence of acanthopanax senti-coside B on the action potential of cultured myocardial cells in rats [J].Bai-qiu-en Yike Daxue Xuebao(J Norman Bethune U-niv Med Sci),1995;21(1):17-19.
  [19]Zhan S,Influence of acanthopanax senticoside C1on the action potential and spontaneous beat of cultured myocardial cells in rats [J].Bai-qiu-en Yike Daxue Xuebao(J Norman Bethune Univ Med Sci),1995;21(6):568-570.
如果您有论文相关需求,可以通过下面的方式联系我们
客服微信:371975100
QQ 909091757 微信 371975100